Teva has opted to settle the first trial among hundreds of cases that accuse it and other drugmakers of helping to fuel the opioid addiction epidemic in the US.
Teva has said it will defend itself against a lawsuit raised by 44 US states that alleges the company was the ringleader in an illegal price-fixing scheme involving 19 other generic compani
